Central Pharmaceuticals Ltd. announcements
203 Dhaka Stock Exchange announcements for Central Pharmaceuticals Ltd. (CENTRALPHL) since 2013: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2024 (19).
- Resumption After Record Date
Trading of the shares of the company will resume on 28.11.2024.
- Suspension for Record Date
Trading of the shares of the company will remain suspended on record date i.e., 27.11.2024.
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle from 24.11.2024 to 26.11.2024 and trading of the shares will remain suspended on record date i.e., 27.11.2024.
- Q1 Financials
(Q1 Un-audited): EPS was Tk. (0.004) for July-September 2024 as against Tk. (0.05) for July-September 2023; NOCFPS was Tk. (0.00) for July-September 2024 as against Tk. (0.00) for July-September 2023. NAV per share was Tk. 7.05 as on September 30, 2024 and Tk. 7.06 as on June 30, 2024.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 14, 2024 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2024.
- Dividend Declaration
The Board of Directors has recommended No dividend for the year ended June 30, 2024. Date of AGM: 30.12.2024, Time: 11:30 AM, Venue: Hall Patio, Gulshan Club Limited, House: Nwj/2/A, Bir Uttom Sultan Mahmud Road, Gulshan 02, Dhaka-1212. Record date: 27.11.2024. The Company has also reported EPS of Tk. (0.35), NAV per share of Tk. 7.06 and NOCFPS of Tk. 0.02 for the year ended June 30, 2024 as against Tk. (0.37), Tk. 5.59 and Tk. (0.00) respectively for the year ended June 30, 2023.
- Price Limit Open
There will be no price limit on the trading of the shares of the Company today (05.11.2024) following its corporate declaration.
- Reschedule of Board Meeting under LR 19(1)
The Company has further informed that due to unavoidable circumstances, the Board meeting under Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, will be held on November 04, 2024 at 3:30 PM instead of October 28, 2024 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2024.
- Dhaka Stock Exchange PLC. (DSE) has accorded its consent to transfer total 21,825,000 shares of Central Pharmaceuticals
Dhaka Stock Exchange PLC. (DSE) has accorded its consent to transfer total 21,825,000 shares of Central Pharmaceuticals Limited comprising 15,100,000 shares of Munsur Ahamed, a sponsor director of the company; 6,725,000 shares of Morsheda Ahmed, a sponsor director of the company (cont.)
- Transfer of shares outside the Trading System of the Exchange
(Continuation news of CENTRALPHL): to IDLC Investments Limited (the transferee) within 30 working days with effect from October 22, 2024 under Regulation 47 (1)(b) of the Dhaka Stock Exchange (Listing) Regulations, 2015 as per court order as well as other applicable laws. (end)
The first part of this announcement is missing from the archive. - Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 28, 2024 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2024.
- Category Change
The Company will be placed in 'Z' category from existing 'B' category with effect from September 26, 2024 as per provision 1(a) of BSEC Directive No. BSEC/CMRRCD/2009-193/77, dated May 20, 2024.
- Prohibition on providing loan facilities to purchase securities
The Stock Brokers and Merchant Bankers are requested to abstain from providing loan facilities to purchase security of Central Pharmaceuticals Limited with effect from September 26, 2024 as per BSEC Directive No. BSEC/CMRRCD/2009-193/32 dated December 26, 2021.
- Q3 Financials
(Q3 Un-audited): EPS was Tk. (0.16) for January-March 2024 as against Tk. (0.05) for January-March 2023; EPS was Tk. (0.31) for July 2023-March 2024 as against Tk. (0.19) for July 2022-March 2023. NOCFPS was Tk. (0.00) for July 2023-March 2024 as against Tk. (0.00) for July 2022-March 2023. NAV per share was Tk. 7.10 as on March 31, 2024 and Tk. 5.59 as on June 30, 2023.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 30, 2024 at 03:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2024.
- Q2 Financials (Repeat)
Repeat news- (Q2 Un-audited): EPS was Tk. (0.09) for October-December 2023 as against Tk. (0.06) for October-December 2022; EPS was Tk. (0.15) for July-December 2023 as against Tk. (0.14) for July-December 2022. NOCFPS was Tk. 0.00 for July-December 2023 as against Tk. (0.00) for July-December 2022. NAV per share was Tk. 5.44 as on December 31, 2023 and Tk. 5.96 as on June 30, 2023.
- Q2 Financials
(Q2 Un-audited): EPS was Tk. (0.09) for October-December 2023 as against Tk. (0.06) for October-December 2022; EPS was Tk. (0.15) for July-December 2023 as against Tk. (0.14) for July-December 2022. NOCFPS was Tk. 0.00 for July-December 2023 as against Tk. (0.00) for July-December 2022. NAV per share was Tk. 5.44 as on December 31, 2023 and Tk. 5.96 as on June 30, 2023.
- Reschedule of Board Meeting under LR 16(1)
The Company has further informed that due to unavoidable circumstances the meeting of the Board of Directors of the Company as per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, will be held on February 07, 2024 at 3:30 PM instead of January 31, 2024 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2023.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 31, 2024 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2023.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.